here is some info on it, since it is only in the trial phase, it would be very hard to find a source with out knowing someone that knows someone, The good news it is fast tracked by the FDA, So there are not as many restrictions on it, you should start being able to find it in a year or so even though it will not be in use for 3 years
Blood-booster drug maker also makes the test
May 21, 2001, Vista, California (
www.triathlonlive.com):
The newest drug in the illicit endurance drug pipeline is RSR-13. It is made by a Denver-based company called Allos Therapeutics, Inc. How new is RSR-13? It is only in its clinical trial stage, which means it isn’t approved yet for use anywhere in the world. Even though RSR-13 is on the FDA fast track, it won’t be available for use for at least 2 to 3 years.
Yet it seems to have found its way into the dufflebags of European cyclists racing in the Giro d’Italia, according to news reports.
Allos' director of corporate communications, Monique Greer, questions this. "We’ve heard the reports, and we’re committed to cooperating, but we haven't heard anything yet [other than what’s been reported in the news]. No investigator or police representative has contacted us, and it’s been two weeks."
What is RSR-13? It is not a blood booster per se, like EPO. It does not add blood cells, it does not raise one’s hematocrit. But it does enhance the ability of blood cells––specifically the hemoglobin carried within red blood cells––to release oxygen. The solution Allos is trying to effect is the oxygenation of cancer cells. Poorly oxygenated cancer cells are not as susceptible to radiation treatment.
But the side-benefit of increased oxygenation at the tissue site has caused Allos to seek to treat many diseases and clinical conditions attributed to or aggravated by oxygen deprivation, or hypoxia. In layman’s terms, this means that RSR-13 won’t give you any more red blood cells, but it’ll maximize the efficiency of those you do have.
News sources are reporting that there is no test to detect RSR-13. The bad news for unscrupulous endurance athletes, though, is that this is temporary. Allos has certainly been aware -- both from the history of other red blood cell enhancers like EPO, and from the simple proximity of Allos Therapeutics, Inc., to two of the world's leading centers of endurance sports athletes (Boulder and Colorado Springs) -- that RSR13 will be attractive to drug cheats. Allos has therefore already developed a test in conjunction with Dr. Don Catlin, chief among the USOC’s anti-doping scientists and head of UCLA’s drug testing lab.
"We’ve been pretty proactive, unlike a lot of companies," said Greer. RSR-13 can be easily detected in urine within 24 hours of use."
Dr. Catlin echoed Greer’s words. When asked if Allos has in fact been a "good citizen" of the pharmaceutical industry by trying to keep this drug out of the hands of the unscrupulous endurance athletes, he answer was an emphatic, "Definately yes."
The test is not yet entirely ready for use, but it appears close. We further asked if the drug's efficacy as an oxygenator is longer-lived than the test, which is to say, might somebody be able to benefit from RSR13 past the point when the test would detect RSR13 usage?
"I doubt it," said Catlin. "But it has not been studied. We do not know yet because the work is in-progress."
The RSR-13 threat seems to be just about over before it’s even started. Score another one for the drug police.
Please Scroll Down to See Forums Below 
